Closed · SOL-OAA-16-000026 · CFDA 98.001 · Discretionary

HIV Vaccine and Biomedical Prevention Research Project

Federal grant opportunity posted by Agency for International Development, cataloged on Grants.gov.

$20M-$160M
Award range
Closed
Status
February 2, 2016
Close date
2
Expected awards

The verdict

HIV Vaccine and Biomedical Prevention Research Project is a closed discretionary listing from Agency for International Development that offered $20,000,000 -- $160,000,000 across 2 expected awards. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 753 other opportunities from Agency for International Development.

$20M-$160M
award range
Closed
application status
2
expected awards
98.001
CFDA program

Archived opportunity record

HIV Vaccine and Biomedical Prevention Researc… is closed (last close February 2, 2016). Check the agency catalog for replacement NOFOs. Agency for International Development still indexes 753 other opportunities here.

According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.

Deadline tracker

Application window closed

Closed February 2, 2016

Posted Dec 11 Closes Feb 2

Est. Total Funding

$180,000,000

Expected Awards

2

Instrument

Cooperative Agreement

Cost Sharing

Required

Description

The HIV/AIDS pandemic continues to be a major global health problem. Despite significantly accelerated implementation of effective prevention and treatment tools to address HIV and AIDS, over 2 million new infections occurred in 2014. Sub-Saharan Africa remains the region most severely affected, bearing the burden of 66% of the HIV positive people in the world. In sub-Saharan Africa, nearly half of the 25.8 million people living with HIV are women. Given the scope of the epidemic, new biomedical tools to prevent HIV are essential. The most promising of these is a safe and effective HIV vaccine that provides durable protection, thus providing a realistic and cost-effective means of reversing HIV on a population level. It is highly unlikely that a global, sustainable solution to the AIDS pandemic will be economically or logistically feasible in the absence of a safe and effective HIV vaccine. Developing and delivering an AIDS vaccine for those most in need will represent a transformational scientific breakthrough and is in lock-step with USAID’s commitment to high-impact development through innovation. Parallel to this noble scientific endeavor supported by USAID since 2001 are concerted efforts to enhance human resources and infrastructure, while creating and nurturing an enabling policy environment and key partnerships in low- and lower middle-income countries that contribute to sustained capacity for science, research and health systems strengthening in the regions most affected by HIV/AIDS.

Catch-all / unrestricted eligibility mark · SOL-OAA-16-000026

Grants.gov marks HIV Vaccine and Biomedical Prevention Researc… with a catch-all / unrestricted eligibility code (Unrestricted / see official listing). Read the official announcement text for the real applicant filter — the code alone is not a door list. Applicant cost-sharing is required on the Grants.gov extract. Instrument: Cooperative Agreement. Funding-activity code maps to Health (HL). This eligibility-code string dominates the Agency for International Development book (340 peers, 45% of 754).

Code 99
Unrestricted / see official listing

Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

Lealie M. Perry

What to do next

HIV Vaccine and Biomedical Prevention Researc… is closed; use the parent program and agency catalog for the next funding cycle.

  • Browse open federal opportunities in the same category when this listing is closed. Open opportunities
  • Look up CFDA 98.001 across all indexed listings before you commit to this opportunity alone. Eligibility finder
  • Compare award ranges across federal categories before you pick a single CFDA. All categories

Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Data sourced from the SAM.gov Assistance Listings and Grants.gov. See our methodology for details. Retrieved and formatted by PlainGrants